FCD-11: A First-in-Class COMPASS Inhibitor in Cancer Therapeutics

Zibo Zhao, Meenal Karunanidhi, Sarah Gold, Luke St John, Rukkia Liaqat, Marta Iwanaszko, Claudia Bigas, Eita Uchida, Kentaro Mineji, Jun Watanabe, Salvador Aznar Benitah, Rintaro Hashizume, Rama K. Mishra, Ali Shilatifard

Open source

DOI: 10.64898/2026.07.30.741768
Published: 2026-07-31
Container: Not recorded
Publisher: openRxiv
Open access: unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
cautionPublication version: Identified as a preprint; peer review and later versions may change the record. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.07.30.741768,
  title = {FCD-11: A First-in-Class COMPASS Inhibitor in Cancer Therapeutics},
  author = {Zibo Zhao and Meenal Karunanidhi and Sarah Gold and Luke St John and Rukkia Liaqat and Marta Iwanaszko and Claudia Bigas and Eita Uchida and Kentaro Mineji and Jun Watanabe and Salvador Aznar Benitah and Rintaro Hashizume and Rama K. Mishra and Ali Shilatifard},
  year = {2026},
  doi = {10.64898/2026.07.30.741768},
  url = {https://doi.org/10.64898/2026.07.30.741768}
}

RIS

TY  - JOUR
TI  - FCD-11: A First-in-Class COMPASS Inhibitor in Cancer Therapeutics
AU  - Zibo Zhao
AU  - Meenal Karunanidhi
AU  - Sarah Gold
AU  - Luke St John
AU  - Rukkia Liaqat
AU  - Marta Iwanaszko
AU  - Claudia Bigas
AU  - Eita Uchida
AU  - Kentaro Mineji
AU  - Jun Watanabe
AU  - Salvador Aznar Benitah
AU  - Rintaro Hashizume
AU  - Rama K. Mishra
AU  - Ali Shilatifard
PY  - 2026
DO  - 10.64898/2026.07.30.741768
UR  - https://doi.org/10.64898/2026.07.30.741768
ER  -

APA

Zhao, Z., Karunanidhi, M., Gold, S., John, L. S., Liaqat, R., Iwanaszko, M., Bigas, C., Uchida, E., Mineji, K., Watanabe, J., Benitah, S. A., Hashizume, R., Mishra, R. K., & Shilatifard, A. (2026). FCD-11: A First-in-Class COMPASS Inhibitor in Cancer Therapeutics. https://doi.org/10.64898/2026.07.30.741768

Source records

crossref · retrieved 2026-09-25T05:51:27.997Z